1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Acute Lung Injury-Pipeline Insights, 2014

Acute Lung Injury-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Acute Lung Injury-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Acute Lung Injury. This report provides information on the therapeutic development based on the Acute Lung Injury dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Acute Lung Injury
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Acute Lung Injury pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Acute Lung Injury and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Acute Lung Injury
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Acute Lung Injury pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Acute Lung Injury-Pipeline Insights, 2014
Table of Contents
- Acute Lung Injury Overview
- Acute Lung Injury Pipeline Therapeutics
- Acute Lung Injury Therapeutics under Development by Companies
- Acute Lung Injury Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Acute Lung Injury Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Acute Lung Injury Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Acute Lung Injury Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Acute Lung Injury - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Acute Lung Injury - Discontinued Products
- Acute Lung Injury - Dormant Products
- Companies Involved in Therapeutics Development for Acute Lung Injury
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Acute Lung Injury, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Acute Lung Injury Assessment by Monotherapy Products
- Acute Lung Injury Assessment by Combination Products
- Acute Lung Injury Assessment by Route of Administration
- Acute Lung Injury Assessment by Stage and Route of Administration
- Acute Lung Injury Assessment by Molecule Type
- Acute Lung Injury Assessment by Stage and Molecule Type
- Acute Lung Injury Therapeutics - Discontinued Products
- Acute Lung Injury Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Acute Lung Injury, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Acute Lung Injury Assessment by Monotherapy Products
- Acute Lung Injury Assessment by Combination Products
- Acute Lung Injury Assessment by Route of Administration
- Acute Lung Injury Assessment by Stage and Route of Administration
- Acute Lung Injury Assessment by Molecule Type
- Acute Lung Injury Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...

Global Respiratory Diagnostic and Monitoring Device Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Product Type, by End User

Global Respiratory Diagnostic and Monitoring Device Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Product Type, by End User

  • $ 5100
  • Industry report
  • December 2016
  • by P&S Market Research

Respiratory diseases are diseases that affects human respiration. Asthma, chronic obstructive pulmonary disease, chronic bronchitis, pulmonary edema, lung cancer, emphysema and cystic fibrosis are some ...

Global Ventilator Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Product Type, by Age Group, by Interface, by Mode by End User

Global Ventilator Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Product Type, by Age Group, by Interface, by Mode by End User

  • $ 5100
  • Industry report
  • December 2016
  • by P&S Market Research

Breathing is a process in which air is inhaled through the mouth or nose, trachea, larynx, pharynx and bronchial tree into the alveoli sacs in the lungs. Normally, this cycle repeats t a breathing rate, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.